| For: | Ali FE, Ibrahim IM, Ghogar OM, Abd-alhameed EK, Althagafy HS, Hassanein EH. Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study. World J Gastroenterol 2023; 29(6): 1026-1053 [PMID: 36844140 DOI: 10.3748/wjg.v29.i6.1026] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v29/i6/1026.htm |
| 编号 | Citing Articles |
| 1 |
Fengmei Liu, Bozong Shao, Yaqin Zhu, Xiaochun Xue, Xiaoyan Wu. Mechanisms of NLRP3 inflammasome in pathogenesis and progression of inflammation-related gastrointestinal diseases. PeerJ 2025; 13: e19828 doi: 10.7717/peerj.19828
|
| 2 |
Misagh Yahya, Javad Safaei-Ghomi, Abdolrasoul Haghir-Ebrahimabadi, Hanieh Jalali, Hossein Mojtabazadeh. Design and biological evaluation of mesalamine–NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapy. Scientific Reports 2025; 16(1) doi: 10.1038/s41598-025-31910-5
|
| 3 |
Run Cao, Jing Jing, Yuting Ma, Wenqing Qi, Xinyu Huang, Chaofang Zhang, Zhizhuo Lu, Jiayi He, Guiling Wang, Yuanfang Ma, Hailong Zhang. Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation. Journal of Inflammation Research 2025; : 1773 doi: 10.2147/JIR.S503033
|
| 4 |
Junyun Luo, Niang Tang, Chenghai Peng, Qun Wang, Shuxi Chen, Aimei Zhou. Intestinal protective effects and mechanisms of finger citron essential oil in dextran sulfate sodium-induced ulcerative colitis mice model. Journal of Functional Foods 2025; 131: 106961 doi: 10.1016/j.jff.2025.106961
|
| 5 |
Limin Chao, Wenjing Zhang, Yuchao Feng, Pei Gao, Jinyou Ma. Pyroptosis: a new insight into intestinal inflammation and cancer. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1364911
|
| 6 |
Osama A. Mohammed, Sameh Saber, Mustafa Ahmed Abdel-Reheim, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Masoud I.E. Adam, Muffarah Hamid Alharthi, Ali M.S. Eleragi, Hanan B. Eltahir, Mohamed Osama Abdalla, Emad Bahashwan, Elwathiq Khalid Ibrahim, Assad Ali Rezigalla, Sameh Abdel-Ghany, Amany A. Alzokaky, Ahmed S. Doghish, Hussein M. El-Husseiny, Mushabab Alghamdi, Mahmoud E. Youssef. Tracking the therapeutic efficacy of a ketone mono ester and β-hydroxybutyrate for ulcerative colitis in rats: New perspectives. Toxicology and Applied Pharmacology 2024; 486: 116943 doi: 10.1016/j.taap.2024.116943
|
| 7 |
Shen Cao, Yi Tai, Shirong Li, Xinzhe Liu, Yanjin Zheng, Jing Han, Weikang Chen, Jingxu Han, Hong Xiang Zuo, Ming Yue Li, Yue Xing, Guimin Zhang, Xuejun Jin, Juan Ma. Network pharmacology and metabolomics reveal Jingfang Granules alleviates DSS-induced colitis via the NF-κB/NLRP3/IL-6/STAT3 pathway. Phytomedicine 2026; 150: 157745 doi: 10.1016/j.phymed.2025.157745
|
| 8 |
Xiao Tong, Li Chen, Shijun He, Shuangshuang Liu, Jiaying Yao, Zhenguang Shao, Yang Ye, Sheng Yao, Zemin Lin, Jianping Zuo. Forsythia suspensa (Thunb.) Vahl extract ameliorates ulcerative colitis via inhibiting NLRP3 inflammasome activation through the TLR4/MyD88/NF‐κB pathway. Immunity, Inflammation and Disease 2023; 11(11) doi: 10.1002/iid3.1069
|
| 9 |
Yujiao Chen, Min Chen, Huifang Chen, Jin-hong Zhu, Chanyang Liang, Sijie Wu, Suda Gu, Weimin Sun, Jie Yan. Crosstalk patterns of necroptosis signaling and NLRP3 inflammasome in the colonic epithelium and its initial role in colitis. International Immunopharmacology 2025; 152: 114413 doi: 10.1016/j.intimp.2025.114413
|
| 10 |
Liang-Kun Zhang, Wen-Chao Gu, Jian Chen. Unveiling Yiyi Fuzi Baijiang powder: Microecological and network pharmacology approach to ulcerative colitis treatment. World Journal of Gastroenterology 2025; 31(42): 111708 doi: 10.3748/wjg.v31.i42.111708
|
| 11 |
Sang Seop Lee, Sang Hoon Lee, So Yeon Kim, Bong Ho Lee, Yung-Choon Yoo. Endarachne binghamiae Extract Alleviates Colitis by Suppressing NLRP3 Inflammasome Activation via Regulation of NOX–iNOS Crosstalk. International Journal of Molecular Sciences 2026; 27(6): 2674 doi: 10.3390/ijms27062674
|
| 12 |
Wenchao Bian, Lili Wei, Kexin Wang. Carthamin yellow alleviates dextran sodium sulfate-induced ulcerative colitis by repairing the intestinal barrier and activating the Nrf2/GPX4 axis. International Immunopharmacology 2024; 141: 113020 doi: 10.1016/j.intimp.2024.113020
|
| 13 |
Yousra Bseiso, Badriyah S. Alotaibi, Alaa A. A. Aljabali, Omar Gammoh, Mohammad E. Rabeh, Ahmad M. Rabi, Esam Qnais, Abdelrahim Alqudah. Protective Effects of Herbacetin in Experimental Colitis: Targeting NF‐κB and NLRP3 Pathways. Drug Development Research 2026; 87(1) doi: 10.1002/ddr.70195
|
| 14 |
Beibei Liu, Marianne R. Spalinger, Annalisa Invernizzi, Eike Gerdes, Babett Steglich, Marlene Schwarzfischer, Andres Machicote, Penelope Pelczar, Doris Pöhlmann, Mikolaj Nawrocki, Marius Böttcher, Ayob Aleko, Lis Noelia Velasquez, Sandra Wende, Franziska Stallbaum, Justus Neuendorff, Saskia Grosshauser, Franziska Muscate, Gemma Douilhet, Laura Garcia Perez, Morsal Sabihi, Katharina Möller, Florian Viehweger, Jan P. Sutter, Christoph Kilian, Yogesh Kumar, Thorben Fründt, Guido Sauter, Thomas Rösch, Nicola Gagliani, Amedeo Caflisch, Michael Scharl, Samuel Huber. Indirect inhibition of the NLRP3-interleukin-1β axis contributes to the efficacy of JAK1 inhibitors in experimental colitis and human ulcerative colitis. Nature Communications 2026; doi: 10.1038/s41467-026-71808-y
|
| 15 |
Yanling Che, Lina Zhao, Haoxuan Xu, Yijiao Cai, Ziqi Wu, Lili Zhong. Serum uric acid to high‑density lipoprotein cholesterol ratio as a novel predictor of diabetic nephropathy: a cross‑sectional analysis of NHANES 2011–2018. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01893-8
|
| 16 |
Nourhan S. Abdeltwab Desoky, Maha A. E. Ahmed, Basma Emad Aboulhoda, Amira M. Abo‐Youssef, Heba M. Mahmoud. Comparative Efficacy of Donepezil and Lamotrigine in Modulating NFκB, PPARγ, and NLRP3 Inflammasome Pathways in Experimental Colitis. Archiv der Pharmazie 2025; 358(11) doi: 10.1002/ardp.70141
|
| 17 |
Peng Yu, Jitao Ling, Yixuan Chen, Panpan Xia, Yuting Wu, Jianqi Liang, Xuehong Zheng, Yunkun Liu, Zhou Xu, Yiming Gan, Ao Shi, Wenting Wang, Xiao Liu, Yaqi Rong, Yan Xiong, Jianping Liu, Xiaoping Yin, Jing Zhang, Deju Zhang. Non‐Starch Purple Sweet Potato Polysaccharide Ameliorates Lipopolysaccharides‐Induced Acute Colitis by Regulating Gut Function and Inactivating the NOD‐Like Receptor Protein 3 Signaling Pathway. Food Frontiers 2026; 7(2) doi: 10.1002/fft2.70248
|
| 18 |
Wenbo Yuan, Qirui Zhao, Jing Hua, Lingyao Xu, Yufan Wang, Tongtong Xu, Zuchao Du, Liping Wu, Daxiang Cui. Oridonin‐Loaded PDA@Gel@GO Nanocapsules Modulate NLRP3 and Epithelial Repair in Colitis. The FASEB Journal 2026; 40(8) doi: 10.1096/fj.202503622R
|
| 19 |
Bayo Olufunso Adeoye, Oyedayo Phillips Akano, Oluwatoyin Michael Daniyan, Peace Awele Mokogwu, Adedayo Hakeem Oyebanji, Modupe Olusola Adetayo, Oludayo Adeyemi Olosunde, Ayodeji David Adeoye, Sandra Onyinyechi Ajaere, Opeyemi Adebola Adetunji, Oluwaseun Adetayo Adewole. A systematic review of inflammasome signalling, diabetes co-morbidities and nutraceuticals: a three-fold cord that can be dietarily broken. Phytochemistry Reviews 2026; doi: 10.1007/s11101-026-10245-7
|
| 20 |
Jiaoyang Xu, Xiaoyu Han, Zizheng Nie, Qinglong Cao, Mu Zhang, Yingying Liu, Chenyang Wu, Jun Yang, Shufen Han. Crocin Supplementation Mitigates DSS‐Induced Ulcerative Colitis by Promoting Autophagy and Modulating Gut Microbiota in Mice. Food Science & Nutrition 2026; 14(4) doi: 10.1002/fsn3.71711
|
| 21 |
Mengru Zhou, Xiaoyao Ma, Jiaqi Zhang, Xuan Lu. 3,5-Dimethyl-8-methoxy-3,4-dihydro-1H-isochromen-6-ol Attenuates Ulcerative Colitis via Targeting NLRP3 in Mice. Journal of Agricultural and Food Chemistry 2024; 72(30): 16700 doi: 10.1021/acs.jafc.4c00971
|
| 22 |
Mohammad Mohammadi, Kaveh Rahimi, Anahita Rezaie, Mohammad Reza Tabandeh. The role of fecal microbiota transplantation on the NLRP3-Caspase 1 pathway and anxiety like behavioral in the ulcerative colitis model in rats. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-96948-x
|
| 23 |
Yan Huang, Zhuolin Ma, Xiaonan Xu, Zhaoxia Liu. Mechanism of Morbidity Based on Ulcerative Colitis: A Review of Traditional Chinese Medicine Treatment of Ulcerative Colitis. International Journal of General Medicine 2025; : 5811 doi: 10.2147/IJGM.S532534
|
| 24 |
Mengmeng Zhang, Xuan Qu. Research Progress on Mechanism of Shikonin in Treatment of Colitis. Journal of Contemporary Medical Practice 2024; 6(10): 167 doi: 10.53469/jcmp.2024.06(10).34
|
| 25 |
Ya-Ju Yu, Wu-Chien Chien. Comparative risks of inflammatory bowel disease in patients with type 2 diabetes mellitus treated with SGLT-2 inhibitors versus DPP-4 inhibitors: a real-world nationwide cohort study. International Journal of Clinical Pharmacy 2025; 47(6): 2037 doi: 10.1007/s11096-025-02026-7
|
| 26 |
Lingling Yuan, Wei Li, Shuangyuan Hu, Yingyi Wang, Shaofeng Wang, Huai’e Tian, Xuhui Sun, Xuli Yang, Mengyun Hu, Yi Zhang. Protective effects of ginsenosides on ulcerative colitis: a meta-analysis and systematic review to reveal the mechanisms of action. Inflammopharmacology 2024; 32(5): 3079 doi: 10.1007/s10787-024-01516-w
|
| 27 |
Chou-Yi Hsu, Mohammed Ahmed Mustafa, Thabit Moath Omar, Sada Gh Taher, Mohammed Ubaid, Nataliya S. Gilmanova, Mustafa Nasrat Abdulraheem, Mohamed J. Saadh, Aya H. Athab, Rasoul Mirzaei, Sajad Karampoor. Gut instinct: harnessing the power of probiotics to tame pathogenic signaling pathways in ulcerative colitis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1396789
|
| 28 |
Zhongbao Niu, Xinhong Li, Xiuhua Yang, Zhongwei Sun. Protective effects of sinomenine against dextran sulfate sodium-induced ulcerative colitis in rats via alteration of HO-1/Nrf2 and inflammatory pathway. Inflammopharmacology 2024; 32(3): 2007 doi: 10.1007/s10787-024-01455-6
|
| 29 |
Yana Ma, Wen Luo, Weijia Zhu, Zhichao Deng, Shijun Xu, Hang Yuan, Wei-jun Fan, Quanjun Yao, Wei Yao, Ho-Young Song, Mingzhen Zhang, Jizhao Wang, Hongtao Hu. Chrysanthemum-derived carbon dots alleviate colitis by dual targeting and regulating Keap1/Nrf2 and NF-κB/NLRP3 signaling pathways. Chemical Engineering Journal 2026; 537: 176544 doi: 10.1016/j.cej.2026.176544
|
